Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The 4ditc ad-hoc imaging ciao (complete irradiated area outline) calculation results in a ciao shape that differs from the ciao calculated in ariachart eclipse offline review and on-board imager. the 4ditc algorithm adds dose for the control point at the field edge which should not be added according to the system specifications. this error will be present in the 4ditc mlc display. the discrepancy is a display issue that is only seen when an ad-hoc image template has been added after the plan has been loaded on the 4ditc. if the 4ditc generated ciao image is projected on the patient using the light field the incorrect field edge will be displayed. if the field edge is used to set-up another abutting treatment field the area between the projected field edge and the abutting field edge would be mismatched and not treated.